| Patent | Date |
|---|
Cardiovascular Risk Evaluations Using a Risk Parameter That Includes an HDL and Inflammatory Biomarker Interaction Parameter
App 20220137076 - Otvos; James D. ; et al. | 2022-05-05 |
Multi-Parameter Metabolic Vulnerability Index Evaluations
App 20220043013 - Otvos; James D. ; et al. | 2022-02-10 |
NMR Analyzers for Clinical Evaluation of Biosamples
App 20220043086 - Otvos; James D. ; et al. | 2022-02-10 |
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
Grant 11,231,429 - Otvos , et al. January 25, 2 | 2022-01-25 |
Methods To Predict Liver Disease Mortality Using Lipoprotein Lp-z
App 20220011388 - Jiang; Zhenghui Gordon ; et al. | 2022-01-13 |
Multi-parameter metabolic vulnerability index evaluations
Grant 11,156,621 - Otvos , et al. October 26, 2 | 2021-10-26 |
NMR analyzers for clinical evaluation of biosamples
Grant 11,156,685 - Otvos , et al. October 26, 2 | 2021-10-26 |
Multiple-Marker Risk Parameters Predictive of Conversion to Diabetes
App 20210304898 - Otvos; James D. ; et al. | 2021-09-30 |
Methods and systems for predicting colorectal cancer incidence and mortality
Grant 11,124,837 - Otvos , et al. September 21, 2 | 2021-09-21 |
Multiple-marker risk parameters predictive of conversion to diabetes
Grant 11,037,683 - Otvos , et al. June 15, 2 | 2021-06-15 |
NMR Measurements of NMR Biomarker GlycA
App 20210080452 - Otvos; James D. ; et al. | 2021-03-18 |
NMR measurements of NMR biomarker GlycA
Grant 10,852,293 - Otvos , et al. December 1, 2 | 2020-12-01 |
NMR Quantification of TMAO
App 20200355634 - Otvos; James D. ; et al. | 2020-11-12 |
NMR quantification of TMAO
Grant 10,613,044 - Otvos , et al. | 2020-04-07 |
Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements
App 20200066370 - Otvos; James D. | 2020-02-27 |
Multi-Parameter Diabetes Risk Evaluations
App 20200005943 - Otvos; James D. ; et al. | 2020-01-02 |
CHD Risk Stratification Evaluations for Subjects With High Levels of Large HDL-P
App 20200003752 - Otvos; James D. ; et al. | 2020-01-02 |
Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements
Grant 10,504,610 - Otvos Dec | 2019-12-10 |
NMR Analyzers for Clinical Evaluation of Biosamples
App 20190317165 - Otvos; James D. ; et al. | 2019-10-17 |
Multi-parameter diabetes risk evaluations
Grant 10,388,414 - Otvos , et al. A | 2019-08-20 |
CHD risk stratification evaluations for subjects with high levels of large HDL-P
Grant 10,386,355 - Otvos , et al. A | 2019-08-20 |
NMR analyzers for clinical evaluation of biosamples
Grant 10,365,339 - Otvos , et al. July 30, 2 | 2019-07-30 |
Methods and Systems to Detect and Quantify the Amount of LP-X and Other Abnormal Lipoproteins in a Biosample Using NMR Spectrosc
App 20190145990 - Otvos; James D. ; et al. | 2019-05-16 |
Multi-Parameter Metabolic Vulnerability Index Evaluations
App 20190072572 - Otvos; James D. ; et al. | 2019-03-07 |
Cardiovascular Risk Evaluations Using a Risk Parameter that Includes an HDL and Inflammatory Biomarker Interaction Parameter
App 20180196075 - Otvos; James D. ; et al. | 2018-07-12 |
Multiple-Marker Risk Parameters Predictive of Conversion to Diabetes
App 20180158554 - Otvos; James D. ; et al. | 2018-06-07 |
Methods and Systems for Predicting Colorectal Cancer Incidence and Mortality
App 20180112274 - Otvos; James D. ; et al. | 2018-04-26 |
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
Grant 9,952,232 - Otvos , et al. April 24, 2 | 2018-04-24 |
Multiple-marker risk parameters predictive of conversion to diabetes
Grant 9,928,345 - Otvos , et al. March 27, 2 | 2018-03-27 |
Multi-parameter diabetes risk evaluations
Grant 9,792,410 - Otvos , et al. October 17, 2 | 2017-10-17 |
Nmr Quantification Of Tmao
App 20170184521 - Otvos; James D. ; et al. | 2017-06-29 |
Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements
App 20170083663 - Otvos; James D. | 2017-03-23 |
CHD Risk Stratification Evaluations for Subjects with High Levels of Large HDL-P
App 20170017772 - OTVOS; JAMES D. ; et al. | 2017-01-19 |
NMR quantification of TMAO
Grant 9,541,620 - Otvos , et al. January 10, 2 | 2017-01-10 |
NMR Measurements of NMR Biomarker GlycA
App 20170003269 - Otvos; James D. ; et al. | 2017-01-05 |
NMR quantification of TMAO
Grant 9,535,144 - Otvos , et al. January 3, 2 | 2017-01-03 |
NMR measurement of clinically relevant ionized biosample constituents such as ionized calcium and/or magnesium
Grant 9,494,666 - Jeyarajah , et al. November 15, 2 | 2016-11-15 |
Multi-Parameter Diabetes Risk Evaluations
App 20160321424 - Otvos; James D. ; et al. | 2016-11-03 |
Protective HDL particle number evaluations
Grant 9,483,611 - Otvos , et al. November 1, 2 | 2016-11-01 |
CHD risk stratification evaluations for subjects with high levels of large HDL-P
Grant 9,483,612 - Otvos , et al. November 1, 2 | 2016-11-01 |
NMR measurements of NMR biomarker GlycA
Grant 9,470,771 - Otvos , et al. October 18, 2 | 2016-10-18 |
Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements
Grant 9,435,870 - Otvos September 6, 2 | 2016-09-06 |
Multi-parameter diabetes risk evaluations
Grant 9,361,429 - Otvos , et al. June 7, 2 | 2016-06-07 |
Cardiovascular Risk Evaluations Using A Risk Parameter That Includes An Hdl And Inflammatory Biomarker Interaction Parameter
App 20160077116 - Otvos; James D. ; et al. | 2016-03-17 |
Nmr Quantification Of Tmao
App 20150149094 - Otvos; James D. ; et al. | 2015-05-28 |
Multi-parameter Diabetes Risk Evaluations
App 20150149095 - Otvos; James D. ; et al. | 2015-05-28 |
Multiple-marker Risk Parameters Predictive Of Conversion To Diabetes
App 20150127267 - Otvos; James D. ; et al. | 2015-05-07 |
Nmr Analyzers For Clinical Evaluation Of Biosamples
App 20140184223 - Otvos; James D. ; et al. | 2014-07-03 |
NMR analyzers for clinical evaluation of biosamples
Grant 8,704,521 - Otvos , et al. April 22, 2 | 2014-04-22 |
Multi-parameter Diabetes Risk Evaluations
App 20130332082 - Otvos; James D. ; et al. | 2013-12-12 |
Nmr Measurements Of Glyca
App 20130328561 - Otvos; James D. ; et al. | 2013-12-12 |
Nmr Quantification Of Tmao
App 20130325353 - Otvos; James D. ; et al. | 2013-12-05 |
Protective Hdl Particle Number Evaluations
App 20130289884 - Otvos; James D. ; et al. | 2013-10-31 |
Chd Risk Stratification Evaluations For Subjects With High Levels Of Large Hdl -p
App 20130289885 - Otvos; James D. ; et al. | 2013-10-31 |
Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same
Grant 8,386,187 - Otvos February 26, 2 | 2013-02-26 |
Nmr Analyzers For Clinical Evaluation Of Biosamples
App 20110295517 - Otvos; James D. ; et al. | 2011-12-01 |
NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples
Grant 8,013,602 - Otvos , et al. September 6, 2 | 2011-09-06 |
Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements
Grant 7,790,465 - Otvos September 7, 2 | 2010-09-07 |
Lipoprotein Insulin Resistance Indexes And Related Methods, Systems And Computer Programs For Generating Same
App 20100100334 - Otvos; James D. | 2010-04-22 |
Methods, Systems And Computer Programs For Assessing Chd Risk Using Adjusted Hdl Particle Number Measurements
App 20070264677 - Otvos; James D. | 2007-11-15 |
NMR Measurement of Clinically Relevant Ionized Biosample Constituents Such As Ionized Calcium and/or Magnesium
App 20070178598 - Jeyarajah; Elias ; et al. | 2007-08-02 |
Methods, Systems And Computer Programs For Assessing Chd Risk Using Adjusted Ldl Particle Number Measurements
App 20060183234 - Otvos; James D. | 2006-08-17 |
NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples
App 20050222504 - Otvos, James D. ; et al. | 2005-10-06 |
Methods for providing personalized lipoprotein-based risk assessments
Grant 6,653,140 - Otvos November 25, 2 | 2003-11-25 |
Method of determining presence and concentration of lipoprotein X in blood plasma and serum
Grant 6,617,167 - Otvos , et al. September 9, 2 | 2003-09-09 |
Methods for providing personalized lipoprotein-based risk assessments
App 20030119194 - Otvos, James D. | 2003-06-26 |
Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results
Grant 6,576,471 - Otvos June 10, 2 | 2003-06-10 |
Method of determining presence and concentration of lipoprotein X in blood plasma and serum
App 20030054559 - Otvos, James D. ; et al. | 2003-03-20 |
Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders
Grant 6,518,069 - Otvos , et al. February 11, 2 | 2003-02-11 |
Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results
App 20020087276 - Otvos, James D. | 2002-07-04 |
Method and apparatus for measuring classes and subclasses of lipoproteins
Grant 5,343,389 - Otvos August 30, 1 | 1994-08-30 |
Measurement of blood lipoprotein constituents by analysis of data acquired from an NMR spectrometer
Grant 4,933,844 - Otvos June 12, 1 | 1990-06-12 |
| 